Ira Winer, MD, Obstetrics & Gynecology, Detroit, MI, Karmanos Cancer Center

IraSethWinerMDPhD

Obstetrics & Gynecology Detroit, MI

Gynecologic Oncology

Gynecologic Oncology, Karmanos Cancer Institute Associate Professor, Wayne State University

Overview of Dr. Winer

Dr. Ira Winer is an obstetrician/gynecologist in Detroit, MI and is affiliated with multiple hospitals in the area, including Karmanos Cancer Center, McLaren Oakland, and DMC Harper University Hospital. He received his medical degree from University of Michigan Medical School and has been in practice 10 years. He is one of 23 doctors at Karmanos Cancer Center and one of 17 doctors at McLaren Oakland who specialize in Obstetrics & Gynecology. He also speaks multiple languages, including Hebrew.

Education & Training

  • Wayne State University School of Medicine
    Wayne State University School of MedicineFellowship, Gynecological Oncology, 2011 - 2015
  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersResidency, Obstetrics and Gynecology, 2007 - 2011
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2007
  • University of Michigan
    University of MichiganPhD, The Cellular and Molecular Biology Program, 2001 - 2005
  • Boston University
    Boston UniversityBA, Biochemistry, Molecular Biology, Summa Cum Laude, 1999

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2024
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CCITLA award NCI, 2019-2020
  • 1st Prize in Fellow Research Section ACOG Research, 2012
  • Distinction in Research University of Michigan Medical School, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease  
    Winer IS, Lonardo F, Johnson SC, Deppe G., Am J Obstet Gynecol, 3/30/2013
  • Chemotherapy of vulvar cancer: A Review  
    Deppe G, Mert I, Belotte J, WinerIS, Wien KlinWochenschr, 3/1/2013
  • Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium: A Multi-institutional Study  
    Seeman A, Mert I, Munkarah A, Bandyopadhyay S, Winer I, et al., Int J GynecolPathol, 3/1/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • The significance of squamous vs. adenocarcinoma subtypes in early stage cervical carcinoma
    Winer I, Alvarado-Cabrero I, Seward S, Valencia-Cedillo R, Munkarah A, Ali-Fehmi R., American Association of Cancer Research Annual Meeting, 4/1/2013
  • A multi-institutional clinic-pathologic study of USC without myometrial invasion
    Winer I, Semaan A,Mert I, Hayek K, Bandyopadhyay S, Nucci MR, Van de Vijver KK, Hussein Y, Alosh B, Oliva E, Ali-Fehmi R, International Gynecologic Cancer Society (IGCS),, 10/1/2012
  • Activation of the unfolded protein response (UPR) by disulfiram in ovarian cancer cells: A novel therapeutic mechanism to overcome chemoresistance
    Winer et al., International Journal of Gynecological Cancer, 10/1/2012
  • Join now to see all

Press Mentions

  • Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting
    Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual MeetingNovember 9th, 2020

Professional Memberships

Other Languages

  • Hebrew

Hospital Affiliations